Orchid Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Orchid Pharma Quarterly Results    (ORCHID)

Here are the latest quarterly results of Orchid Pharma. For more details, see the Orchid Pharma financial fact sheet and Orchid Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Orchid Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-18
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,5581,3061,4251,4851,6211,3581,3101,286 
Other income Rs m1443631945526670 
Turnover Rs m1,5721,3491,4881,5031,6661,4091,3761,356 
Expenses Rs m2,2721,4491,4571,3601,6981,4521,3101,376 
Gross profit Rs m-714-3935125134-940-90 
Depreciation Rs m326328330328313314317316 
Interest Rs m01350000111 
Profit before tax Rs m-1,025-460-231-185-134-356-252-347 
Tax Rs m-1010000000 
Profit after tax Rs m-924-460-231-185-134-356-252-347 
Gross profit margin %-45.8-3.02.58.48.3-6.90.0-7.0 
Effective tax rate %9.90.00.00.00.00.00.00.0 
Net profit margin %-59.3-35.2-16.2-12.4-8.3-26.2-19.2-27.0 
Diluted EPS Rs -10.4 -5.2 -2.6 -2.1 -1.5 -4.0 -2.8 -3.9  
Diluted EPS (TTM) Rs -39.8 -32.1 -26.8 -20.2 -11.4 -10.2 -10.4 -12.2  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Orchid Pharma 2QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   INDRAPRASTHA MEDICAL  FULFORD INDIA  BIOCON   NATCO PHARMA  GLENMARK PHARMA  

Compare ORCHID PHARMA With:   INDRAPRASTHA MEDICAL  FULFORD INDIA  BIOCON   NATCO PHARMA  GLENMARK PHARMA  

Compare ORCHID PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Recover From Day's Low to End Strong; JSW Steel and ICICI Bank Among Top Nifty Gainers(Closing)

Indian share markets recouped early losses during afternoon deals and ended today's volatile session higher.

Views on news

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

Top 3 Nifty ETFs to Buy Now (Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA SHARE PRICE


Apr 22, 2021 03:37 PM

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA

ORCHID PHARMA - ADCOCK INGRAM COMPARISON

COMPARE ORCHID PHARMA WITH

MARKET STATS